Life Sciences News @ Gowlings

November 20, 2009

Use Twitter? Follow Gowlings news on Twitter

Roche's Actemra successful in arthritis study
http://www.reuters.com/article/rbssHealthcareNews/idUSLK56597620091120

US panel backs new claim for Pfizer lung drug
http://www.reuters.com/article/rbssHealthcareNews/idUSN1915775320091119

CHMP turns Merck's Erbitux down again for metastatic NSCLC
http://www.pharmatimes.com/WorldNews/article.aspx?id=16942

Gene protects brain-eaters from mad cow-type disease
http://www.reuters.com/article/scienceNews/idUSTRE5AH5ZY20091118

Mouse study points to treatment for Down syndrome
http://www.reuters.com/article/scienceNews/idUSTRE5AI0EJ20091119

Corn's genetic code uncovered
http://www.cbc.ca/technology/story/2009/11/19/tech-biology-corn-genome.html

First human trials for stem cell blindness therapy
http://www.telegraph.co.uk/health/healthnews/6610503/First-human-trials-for-stem-cell-blindness-therapy.html

Judges: Seattle biotech can pursue $23M claim
http://www.google.com/hostednews/ap/article/ALeqM5hGtZ3FOnmK-QrM1DuE2udBfIanHAD9C2AKEG0

U.S. University Weighs Tighter Limits on Stem Cell Research
http://www.nytimes.com/2009/11/20/us/20stem.html?_r=1&ref=science

House cut in two by crane
http://www.ananova.com/news/story/sm_3569762.html?menu

Life Sciences News @ Gowlings is a daily news service that provides news items of interest to those in the life sciences.

If you wish to subscribe/unsubscribe to any Gowlings newsletter, please visit http://www.gowlings.com/e-form/subscribe.asp and complete our subscription form. By your use of this service you agree to the Terms and Conditions set out at http://www.gowlings.com/resources/newsletterList.asp?intNewsletterTypeId=99. If you do not agree with the Terms and Conditions, please do not use the service.

Please contact LifeSciencesNews@gowlingsnewsletters.com with questions or comments.

Gowlings and Personal Information - Gowlings respects your privacy. Please see Gowlings' Privacy Policy for more information about how our Firm manages your personal information.

Gowlings is an acknowledged leader in business law, technology law, intellectual property and advocacy.